These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 23219328
21. [Presenting signs and symptoms in Gaucher disease]. Erdös M, Tóth J, Maródi L. Orv Hetil; 2002 Oct 13; 143(41):2327-35. PubMed ID: 12434734 [Abstract] [Full Text] [Related]
22. A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia. Motta I, Filocamo M, Poggiali E, Stroppiano M, Dragani A, Consonni D, Barcellini W, Gaidano G, Facchini L, Specchia G, Cappellini MD, Splenomegaly Gaucher Disease study group. Eur J Haematol; 2016 Apr 13; 96(4):352-9. PubMed ID: 26033455 [Abstract] [Full Text] [Related]
23. A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients. Kraoua I, Sedel F, Caillaud C, Froissart R, Stirnemann J, Chaurand G, Flodrops H, Tari S, Gourfinkel-An I, Mathieu S, Belmatoug N, Billette de Villemeur T, Mignot C. Brain Dev; 2011 Feb 13; 33(2):131-9. PubMed ID: 20307947 [Abstract] [Full Text] [Related]
24. Gaucher's disease: clinical, morphologic, and pathogenetic considerations. Lee RE, Peters SP, Glew RH. Pathol Annu; 1977 Feb 13; 12 Pt 2():309-39. PubMed ID: 600549 [No Abstract] [Full Text] [Related]
25. Coagulation abnormalities in type 1 Gaucher disease in children. Deghady A, Marzouk I, El-Shayeb A, Wali Y. Pediatr Hematol Oncol; 2006 Feb 13; 23(5):411-7. PubMed ID: 16728361 [Abstract] [Full Text] [Related]
26. Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians. Mehta A, Belmatoug N, Bembi B, Deegan P, Elstein D, Göker-Alpan Ö, Lukina E, Mengel E, Nakamura K, Pastores GM, Pérez-López J, Schwartz I, Serratrice C, Szer J, Zimran A, Di Rocco M, Panahloo Z, Kuter DJ, Hughes D. Mol Genet Metab; 2017 Nov 13; 122(3):122-129. PubMed ID: 28847676 [Abstract] [Full Text] [Related]
27. Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1. Machaczka M, Markuszewska-Kuczyńska A, Regenthal S, Jurczyszyn A, Gałązka K, Wahlin BE, Klimkowska M. Pol Arch Med Wewn; 2014 Nov 13; 124(11):587-92. PubMed ID: 25188399 [Abstract] [Full Text] [Related]
28. Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease. Dinur T, Bauer P, Beetz C, Cozma C, Becker-Cohen M, Istaiti M, Rolfs A, Skrahina V, Zimran A, Revel-Vilk S. Int J Mol Sci; 2023 Feb 15; 24(4):. PubMed ID: 36835356 [Abstract] [Full Text] [Related]
29. Skin ultrastructural findings in type 2 Gaucher disease: diagnostic implications. Chan A, Holleran WM, Ferguson T, Crumrine D, Goker-Alpan O, Schiffmann R, Tayebi N, Ginns EI, Elias PM, Sidransky E. Mol Genet Metab; 2011 Dec 15; 104(4):631-6. PubMed ID: 21982627 [Abstract] [Full Text] [Related]
30. Diagnosing Gaucher disease. Early recognition, implications for treatment, and genetic counseling. Sidransky E, Tayebi N, Ginns EI. Clin Pediatr (Phila); 1995 Jul 15; 34(7):365-71. PubMed ID: 7554686 [Abstract] [Full Text] [Related]
31. Gaucher Disease and Myelofibrosis: A Combined Disease or a Misdiagnosis? Mariani S, Palumbo G, Cardarelli L, Santopietro M, Foà R, Giona F. Acta Haematol; 2018 Jul 15; 139(4):240-242. PubMed ID: 29945135 [Abstract] [Full Text] [Related]
32. [Diagnostic journey of type 1 Gaucher Disease patients: A survey including internists and hematologists]. Deriaz S, Serratrice C, Lidove O, Noël E, Masseau A, Lorcerie B, Jaussaud R, Marie I, Lavigne C, Cabane J, Kaminsky P, Chérin P, Maillot F, pour le groupe de travail 'médecine interne-maladies rares'. Rev Med Interne; 2019 Dec 15; 40(12):778-784. PubMed ID: 31500934 [Abstract] [Full Text] [Related]
33. Gaucher disease, myelodysplastic syndrome and ICUS. Ruchlemer R, Mittelman M, Zimran A. Blood Cells Mol Dis; 2020 Feb 15; 80():102373. PubMed ID: 31718920 [Abstract] [Full Text] [Related]
35. Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative. Mehta A, Kuter DJ, Salek SS, Belmatoug N, Bembi B, Bright J, Vom Dahl S, Deodato F, Di Rocco M, Göker-Alpan O, Hughes DA, Lukina EA, Machaczka M, Mengel E, Nagral A, Nakamura K, Narita A, Oliveri B, Pastores G, Pérez-López J, Ramaswami U, Schwartz IV, Szer J, Weinreb NJ, Zimran A. Intern Med J; 2019 May 15; 49(5):578-591. PubMed ID: 30414226 [Abstract] [Full Text] [Related]
36. Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia. Motta I, Consonni D, Stroppiano M, Benedetto C, Cassinerio E, Tappino B, Ranalli P, Borin L, Facchini L, Patriarca A, Barcellini W, Lanza F, Filocamo M, Cappellini MD, Splenomegaly Gaucher group. Sci Rep; 2021 Jan 28; 11(1):2594. PubMed ID: 33510429 [Abstract] [Full Text] [Related]
38. [Diagnostic difficulties in Gaucher disease: report of two cases]. Kuliszkiewicz-Janus M, Urbaniak-Kujda D, Nowak E. Pol Arch Med Wewn; 1998 Oct 28; 100(4):337-43. PubMed ID: 10335043 [Abstract] [Full Text] [Related]